Optimizing risk management for post-amputation wound complications in diabetic patients: Focus on glycemic and immunosuppressive control.

Zhi-Peng Li, Jin-Ke Sun, Wei-Ping Fu, Chang-Jiang Zhang
Author Information
  1. Zhi-Peng Li: Second Department of Orthopedics, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China.
  2. Jin-Ke Sun: Third Department of Orthopedics, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China.
  3. Wei-Ping Fu: Second Department of Orthopedics, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China.
  4. Chang-Jiang Zhang: Second Department of Orthopedics, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China. changjiangzhang1968@outlook.com.

Abstract

This study highlights the importance of identifying and addressing risk factors associated with wound complications following transtibial amputation in diabetic patients. These amputations, often necessitated by severe diabetic foot ulcers, carry significant risks of postoperative complications such as infection and delayed wound healing. Elevated hemoglobin A1c levels, indicative of poor glycemic control, and a history of kidney transplantation, due to required immunosuppressive therapy, are key factors influencing these outcomes. This paper emphasizes the need for enhanced glycemic management and personalized postoperative care, particularly for immunocompromised individuals, to minimize complications and improve patient prognosis. Future research should focus on prospective studies to validate targeted interventions and optimize care strategies, ultimately aiming to reduce the healthcare burden associated with diabetic foot complications.

Keywords

References

  1. Altern Ther Health Med. 2024 Apr;30(4):180-184 [PMID: 37883776]
  2. Diabetes Care. 2018 Jul;41(7):1478-1485 [PMID: 29661917]
  3. Nutrients. 2022 Jan 05;14(1): [PMID: 35011097]
  4. Life (Basel). 2022 Jul 29;12(8): [PMID: 36013336]
  5. Int Wound J. 2022 Oct;19(6):1309-1318 [PMID: 34931460]
  6. Diabetes Care. 2022 Feb 1;45(2):357-364 [PMID: 35007329]
  7. Front Immunol. 2022 Jan 31;13:796456 [PMID: 35173720]
  8. Am J Transplant. 2019 Feb;19(2):501-511 [PMID: 30085388]
  9. Int Wound J. 2023 Dec;20(10):4394-4409 [PMID: 37438679]
  10. World J Diabetes. 2024 Apr 15;15(4):629-637 [PMID: 38680707]
  11. JAMA. 2023 Jul 3;330(1):62-75 [PMID: 37395769]
  12. Prosthet Orthot Int. 2023 Feb 1;47(1):43-53 [PMID: 36791380]
  13. World J Emerg Surg. 2021 Jun 10;16(1):33 [PMID: 34112231]
  14. Bioact Mater. 2022 Jul 01;20:561-573 [PMID: 35846841]
  15. Eur J Orthop Surg Traumatol. 2024 Aug;34(6):2941-2947 [PMID: 38816627]
  16. Front Endocrinol (Lausanne). 2020 Dec 17;11:513073 [PMID: 33391180]
  17. PLoS One. 2018 Dec 11;13(12):e0207583 [PMID: 30533042]
  18. J Bone Joint Surg Am. 2024 May 1;106(9):776-781 [PMID: 38512987]
  19. JAMA Surg. 2017 Aug 01;152(8):784-791 [PMID: 28467526]
  20. BMJ Open. 2020 Sep 30;10(9):e039422 [PMID: 32998928]
  21. Diabetes Metab Res Rev. 2023 Oct;39(7):e3690 [PMID: 37422897]
  22. Evid Based Complement Alternat Med. 2019 Apr 15;2019:7923732 [PMID: 31118970]
  23. J Foot Ankle Res. 2018 Feb 20;11:6 [PMID: 29467829]
  24. BMJ Open. 2024 Apr 23;14(4):e080232 [PMID: 38658012]
  25. Diabetes Care. 2023 Dec 1;46(12):2267-2272 [PMID: 37824790]
  26. J Dev Behav Pediatr. 2022 Dec 1;43(9):e598-e604 [PMID: 35976702]
  27. Diabetes Care. 2023 Apr 1;46(4):845-853 [PMID: 36787983]
  28. Anesthesiology. 2009 Feb;110(2):408-21 [PMID: 19194167]
  29. Horm Mol Biol Clin Investig. 2024 Sep 24;: [PMID: 39308003]
  30. Antibiotics (Basel). 2023 Jun 12;12(6): [PMID: 37370360]
  31. Diabetes Care. 2024 Jun 1;47(6):921-923 [PMID: 38768332]
  32. J Clin Res Pediatr Endocrinol. 2024 Nov 20;: [PMID: 39564967]

Word Cloud

Created with Highcharts 10.0.0complicationsdiabeticfactorswoundfootglycemiccontrolcareriskassociatedamputationpostoperativeA1ctransplantationimmunosuppressivetherapyoutcomesmanagementstudyhighlightsimportanceidentifyingaddressingfollowingtranstibialpatientsamputationsoftennecessitatedsevereulcerscarrysignificantrisksinfectiondelayedhealingElevatedhemoglobinlevelsindicativepoorhistorykidneyduerequiredkeyinfluencingpaperemphasizesneedenhancedpersonalizedparticularlyimmunocompromisedindividualsminimizeimprovepatientprognosisFutureresearchfocusprospectivestudiesvalidatetargetedinterventionsoptimizestrategiesultimatelyaimingreducehealthcareburdenOptimizingpost-amputationpatients:FocusDiabeticGlycemicHemoglobinImmunosuppressiveKidneyPersonalizedPostoperativeRiskTranstibialWound

Similar Articles

Cited By